We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,498

Community Outreach Pharmacy Ltd. v. British Columbia (Minister of Health)
  • Harper Grey LLP
  • Canada
  • March 29 2016

The petitioner, a pharmacy, in a judicial review petition for an interlocutory injunction, sought two orders in the nature of certiorari quashing the


Eli Lilly’s Cialis patent withstands double patenting and utility challenges on appeal
  • Gowling WLG
  • Canada
  • April 26 2016

The Federal Court of Appeal has provided guidance on the law of obviousness-type double patenting in dismissing Mylan’s appeal pertaining to Eli


Medically-Assisted Dying - Where are we, and where are we going?
  • MacPherson Leslie & Tyerman LLP
  • Canada
  • April 21 2016

There have been a number of recent developments in medically-assisted Dying in Canada, but the rules that will apply remain unclear. This blog


Federal Court Rules Patients Have Right to Grow Medical Marijuana
  • MacPherson Leslie & Tyerman LLP
  • Canada
  • April 25 2016

On February 24, 2016, the Federal Court of Canada in Allard v Canada 2016 FC 236, ruled that Canadians have a constitutional right under section 7 of


Sobeys West Inc. v. College of Pharmacists of British Columbia
  • Harper Grey LLP
  • Canada
  • March 29 2016

A bylaw prohibiting pharmacists from using customer incentive programs was struck down on judicial review on the basis of unreasonableness. The


Sobeys West Inc. v. Alberta College of Pharmacists
  • Harper Grey LLP
  • Canada
  • April 26 2016

The Applicant, Sobeys West Inc., sought judicial review of new regulations adopted by the Respondent, the Alberta College of Pharmacists. The Court


The SCC Monitor (19042016)
  • McCarthy Tétrault LLP
  • Canada
  • April 19 2016

The SCC recently granted leave to appeal from the judgment of the B.C. Court of Appeal in Douez v. Facebook (“Douez”), which likely garnered


Medical Marijuana in the Workplace: Employer Rights “Up in Smoke”?
  • Aird & Berlis LLP
  • Canada
  • March 28 2016

Employers in Canada understand that they must maintain a safe work environment for their employees. They also understand that when it comes to


Largest Patent Infringement Award in Canada Stands: Apotex Denied Leave to Appeal to the SCC
  • McCarthy Tétrault LLP
  • Canada
  • April 14 2016

Today, the Supreme Court of Canada denied Apotex’s final attempt at obtaining leave to appeal in the storied patent battle between Merck and Apotex


Federal Court finds that generic manufacturer is estopped from re-litigating patent validity in regard to a related product
  • Norton Rose Fulbright Canada LLP
  • Canada
  • October 27 2009

On October 19, 2009 Justice Martineau of the Federal Court held that Apotex's notice of allegation ("NOA") in respect of Canadian Patent No. 2,041,113 (the "Patent") and the drug ZYPREXA was null, void and of no effect, as Apotex had previously made allegations of invalidity in respect of each claim of the Patent